Oncolys BioPharma
Latest round
- Series C
Last raised
- Oct 2006
Total raised
- $22M
Investors
- 5
About Oncolys BioPharma
Oncolys BioPharma Inc.Oncolys BioPharma Inc. was founded in 2004 and is headquartered in Tokyo, Japan. The company specializes in the development of therapeutic solutions for cancer and viral infections.Oncolys BioPharma Inc. specializes in the research and development of innovative therapeutics, focusing on oncology and infectious diseases. The company’s core offerings include investigational cancer therapies targeting specific tumor markers to enhance treatment efficacy and minimize side effects. Its technology aims to provide personalized treatment protocols for diverse patient populations across North America, Europe, and parts of Asia.In the most recent year, 2023, Oncolys BioPharma Inc.6.Oncolys BioPharma Inc. is focusing on the development of new cancer and infectious disease therapies, with plans to launch several investigational products in the upcoming years. The company aims to expand its presence in North America and Europe by the end of 2025.
Who invested in Oncolys BioPharma
5 investors across 2 rounds
See all investors in Oncolys BioPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Oncolys BioPharma
Who invested in Oncolys BioPharma?
Oncolys BioPharma has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Oncolys BioPharma raised?
Oncolys BioPharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Oncolys BioPharma last raise money?
Oncolys BioPharma's most recent round on record is a Series C, in Oct 2006.
What does Oncolys BioPharma do?
Oncolys BioPharma is a pharmaceuticals company.
Where is Oncolys BioPharma headquartered?
Oncolys BioPharma is headquartered in Tokyo, Japan.
Which VCs invest in companies like Oncolys BioPharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Oncolys BioPharma's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Oncolys BioPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.